...
首页> 外文期刊>Veterinary Immunology and Immunopathology >GeneScan analysis to detect clonality of T-cell receptor gamma gene rearrangement in feline lymphoid neoplasms
【24h】

GeneScan analysis to detect clonality of T-cell receptor gamma gene rearrangement in feline lymphoid neoplasms

机译:GeneScan分析检测猫淋巴瘤中T细胞受体γ基因重排的克隆性

获取原文
获取原文并翻译 | 示例

摘要

Lymphoid neoplasms are usually diagnosed on the basis of cytological and histopathological findings. However, in some cases, discrimination of lymphoid neoplasms from reactive lymphoid proliferation is difficult. Polymerase chain reaction (PCR) amplification of the complementarity-determining region (CDR) 3 of the T-cell receptor(TCR) gamma gene can be used to assess clonality of T-cell populations as a supportive diagnostic tool for T-cell neoplasms. Because the length variation in the TCR gamma CDR3 is relatively small, false positive results may occur in non-neoplastic T-cell populations in the absence of high-resolution analytical methods for PCR products. In the present study, a PCR assay system was developed to detect clonal TCR gamma gene rearrangement in feline lymphoid cells using GeneScan analysis. Thirty T-cell neoplasms, 27 B-cell neoplasms, and 34 non-neoplastic tissues were subjected to the newly developed TCR gamma gene rearrangement analysis. Clonal TCR gamma gene rearrangement was detected in 26 of 30 (87%) T-cell neoplasms, 2 of 27 (7%) B-cell neoplasms, and 1 of 34(3%) non-neoplastic tissues. To compare GeneScan analysis with conventional PAGE and heteroduplex analysis, 20 clonal and 20 polyclonal samples were subjected to both analyses. Most of the results were concordant between the 2 analyses; however, several clonal peaks (bands) appeared as a single band when analyzed via conventional PAGE with heteroduplex analysis in 4 of the 20 (20%) clonal samples as a result of the difference in resolution. The PCR assay system to detect clonal TCR gamma gene rearrangement in feline lymphoid cells, using GeneScan analysis, would be a useful molecular diagnostic tool for feline T-cell neoplasms, with high fidelity. (C) 2011 Elsevier B.V. All rights reserved.
机译:淋巴瘤通常根据细胞学和组织病理学发现进行诊断。但是,在某些情况下,很难区分淋巴瘤与反应性淋巴瘤增生。 T细胞受体(TCR)γ基因的互补决定区(CDR)3的聚合酶链反应(PCR)扩增可用于评估T细胞群体的克隆性,作为T细胞肿瘤的辅助诊断工具。因为TCRγCDR3的长度变化相对较小,所以在没有高分辨率PCR方法的情况下,非肿瘤T细胞群体可能会出现假阳性结果。在本研究中,开发了一种PCR检测系统,用于使用GeneScan分析检测猫淋巴细胞中的克隆TCRγ基​​因重排。对30个T细胞肿瘤,27个B细胞肿瘤和34个非肿瘤组织进行了新开发的TCRγ基​​因重排分析。在30个T细胞肿瘤中的26个(87%),27个细胞(7%)中的2个和34个(3%)非肿瘤组织中的1个中检测到了克隆的TCRγ基​​因重排。为了将GeneScan分析与常规PAGE和异源双链分析进行比较,对20个克隆样本和20个多克隆样本都进行了分析。大部分结果在两次分析之间是一致的。但是,由于分辨率的差异,在20个克隆样本中有4个(20%)通过常规PAGE和异源双链分析进行分析时,几个克隆峰(条带)显示为一条条带。利用GeneScan分析技术检测猫淋巴样细胞中克隆性TCRγ基​​因重排的PCR检测系统,将是一种具有高保真度的猫T细胞肿瘤有用的分子诊断工具。 (C)2011 Elsevier B.V.保留所有权利。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号